Browse > Article
http://dx.doi.org/10.7586/jkbns.2021.23.4.298

Risk Factors for Cardiac Implantable Electronic Device-Related Infections  

Park, Jin Yeong (Department of Nursing, Asan Medical Center, Registered Nurse)
Choi, Hye-Ran (Department of Clinical Nursing, University of Ulsan)
Publication Information
Journal of Korean Biological Nursing Science / v.23, no.4, 2021 , pp. 298-307 More about this Journal
Abstract
Purpose: This study aimed to investigate the risk factors for cardiac implantable electronic device (CIED)-related infections within the first post-procedural year after CIED insertion. Methods: This study included 509 adult patients undergoing CIED implantation procedures between January 1, 2011 and December 31, 2015. The data were analyzed by t-test, chi-square test, Fisher's exact test, and logistic regression analysis using SPSS/WIN 23.0. Results: Fifteen infections and 494 non-infections were examined. The CIED-related infection rate was 2.9%; patients with 14 pocket infections and one bacteremia were included in the CIED-related infection. The risk factors of CIED-related infections were the estimated glomerular filtration rate (eGFR) of ≤ 45 mL/min/1.73 m2 (Odds ratio [OR]= 4.03, 95% confidence interval [CI],1.15-14.10) and taking a new oral anticoagulant (NOAC) (OR = 4.50, 95% CI 1.09-18.55). Conclusion: These results identified the CIED infection rate and risk factors of CIED-related infection. It is necessary to consider these risk factors before the CIED implantation procedure and to establish the relevant nursing interventions.
Keywords
Artificial Pacemaker; Infections; Risk Factors; Glomerular Filtration Rate;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Sung SC. 2015 main surgery statistical yearbook page[Internet]. Seoul: National Health Insurance Service; 2016 Nov [cited 2021 Sep 8]. Available from: https://www.nhis.or.kr/nhis/together/wbhaec06800m01.do?mode=view&articleNo= 122272&article.offset=0&articleLimit=10
2 Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing and Clinical Electrophysiology. 2006;29(2):142-145. https://doi.org/10.1111/j.1540-8159.2006.00307.x   DOI
3 Johansen JB, Jorgensen OD, Moller M, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. European Heart Journal. 2011;32(8):991-998. https://doi.org/10.1093/eurheartj/ehq497   DOI
4 Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116(12):1349-1355. https://doi.org/10.1161/CIRCULATIONAHA.106.678664   DOI
5 de Oliveira JC, Martinelli M, Nishioka SAD, Varejao T, Uipe D, Pedrosa AAA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: Results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circulation: Arrhythmia and Electrophysiology. 2009;2(1):29-34. https://doi.org/10.1161/CIRCEP.108.795906   DOI
6 Spinler SA, Nawarskas JJ, Foote EF, Sabapathi D, Connors JE, Marchlinski FE. Clinical presentation and analysis of risk factors for infectious complications of implantable cardioverter-defibrillator implantations at a university medical center. Clinical Infectious Diseases. 1998;26(5):1111-1116. https://doi.org/10.1086/520299   DOI
7 Korea Disease Control and Prevention Agency. 2006-2019 acute cardiac arrest survey page[Internet]. Osong: Korea Disease Control and Prevention Agency; 2020 Dec [cited 2021 Sep 7]. Available from: http://www.kdca.go.kr/board/board.es?mid=a20503050000&bid=0021&act=view&list_no=711768
8 Lekkerkerker JC, van Nieuwkoop C, Trines SA, van der Bom JG, Bernards A, van de Velde ET, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart. 2009;95(9):715-720. https://doi.org/10.1136/hrt.2008.151985   DOI
9 Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter defibrillator infections. Journal of the American College of Cardiology. 2007;49(18):1851-1859. https://doi.org/10.1016/j.jacc.2007.01.072   DOI
10 Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code for Biology and Medicine. 2008;3:17. https://doi.org/10.1186/1751-0473-3-17   DOI
11 Guha A, Maddox WR, Colombo R, Nahman NS, Kintziger KW, Waller JL, et al. Cardiac implantable electronic device infection in patients with end-stage renal disease. Heart Rhythm Society. 2015;12(12):2395-2401. https://doi.org/10.1016/j.hrthm.2015.08.003   DOI
12 Kuriachan VP, Sumner GL, Mitchell LB. Sudden cardiac death. Current Problems in Cardiology. 2015;40(4):133-200. https://doi.org/10.1016/j.cpcardiol.2015.01.002   DOI
13 Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the united states 1993 to 2008. Journal of the American College of Cardiology. 2011;58(10):1001-1006. https://doi.org/10.1016/j.jacc.2011.04.033   DOI
14 Goldberger Z, Lampert R. Implantable cardioverter defibrillators expanding indications and technologies. The Journal of the American Medical Association. 2006;295(7):809-818. https://doi.org/10.1001/jama.295.7.809   DOI
15 Earley A, Persson R, Garlitski AC, Balk EM, Uhlig K. Effectiveness of implantable cardioverter defibrillators for primary prevention of sudden cardiac death in subgroups : a systematic review. Annals of Internal Medicine. 2014;160(2): 111-121. https://doi.org/10.7326/M13-1787   DOI
16 Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458-477. https://doi.org/10.1161/CIRCULATIONAHA.109.192665   DOI
17 Kim YI. 2019 main surgery statistical yearbook page [Internet]. Wonju: National Health Insurance Service; 2020 Nov [cited 2021 Sep 8]. Available from: https://www.nhis.or.kr/nhis/together/wbhaec06800m01.do?mode=view&articleNo=10803657&article.offset=0&articleLimit=10
18 Quinn S, Elhadi M, Weedle R, Nolan P, Keane S, Murphy T, et al. 15 Cardiac implantable electronic device complications in a real-world setting. Heart. 2019;105:A13-A14. https://doi.org/10.1136/heartjnl-2019-ICS.15   DOI
19 Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, Divakara Menon SM, et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. Journal of Cardiovascular Electrophysiology. 2010;21(7):786-790. https://doi.org/10.1111/j.1540-8167.2009.01690.x   DOI
20 Margey R, McCann H, Blake G, Keelan E, Galvin J, Lynch M, et al. Contemporary management of and outcomes from cardiac device related infections. Europace. 2010;12(1):64-70. https://doi.org/10.1093/europace/eup362   DOI
21 Landolina M, Gasparini M, Lunati M, Iacopino S, Boriani G, Bonanno C, et al. Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database. Circulation. 2011;123(22):2526-2535. https://doi.org/10.1161/CIRCULATIONAHA.110.015024   DOI
22 Raad D, Irani J, Akl EG, Choueiri S, Azar E, Abboud J, et al. Implantable electrophysiologic cardiac device infections: a risk factor analysis. European Journal of Clinical Microbiology & Infectious Diseases. 2012;31(11):3015-3021. https://doi.org/10.1007/s10096-012-1655-1   DOI
23 Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology. 1996;49(12):1373-1379. https://doi.org/10.1016/S0895-4356(96)00236-3   DOI
24 Darouiche RO. Treatment of infections associated with surgical implants. The New England Journal of Medicine. 2004;350(14):1422-1429. https://doi.org/10.1056/NEJMra035415   DOI
25 Yang PS, Jeong JH, You SJ, Yu HT, Kim TH, Sung JH, et al. The burden and risk factors for infection of transvenous cardiovascular implantable electronic device: a nationwide cohort study. Korean Circulation Journal. 2019;49(8):742-752. https://doi.org/10.4070/kcj.2018.0361   DOI
26 Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clinic Proceedings. 2008;83(1):46-53. https://doi.org/10.4065/83.1.46   DOI
27 Sohail MR, Hussain S, Le KY, Dib C, Lohse CM, Friedman PA, et al. Risk factors associated with early- versus late-onset implantable cardioverter defibrillator infections. Journal of Interventional Cardiac Electrophysiology. 2011;31(2):171-183. https://doi.org/10.1007/s10840-010-9537-x   DOI
28 Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Archives of Internal Medicine. 2011;171(20):1821-1828. https://doi.org/10.1001/archinternmed.2011.441   DOI
29 Ann HW, Ahn JY, Jeon YD, Jung IY, Jeong SJ, Joung BY, et al. Incidence of and risk factors for infectious complications in patients with cardiac device implantation. International Journal of Infectious Diseases. 2015;36:9-14. https://doi.org/10.1016/j.ijid.2015.05.011   DOI
30 Metais M, Hebrard A, Duparc A, Mondoly P, Delay M, Lepage B, et al. Cardiac implantable devices: surveillance of surgical site infections and assessment of professional pratices. Archives of Cardiovascular Diseases. 2011;104(5):325-331. https://doi.org/10.1016/j.acvd.2011.02.003   DOI
31 Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Risk factor analysis of permanent pacemaker infection. Clinical Infectious Diseases. 2007;45(2):166-173. https://doi.org/10.1086/518889   DOI
32 Healy CA, Carrillo RG. Renal disease in patients undergoing cardiac implantable electronic device extraction for infectious and non-infectious indications. The Journal of Innovations in Cardiac Rhythm Management. 2015;6(5):2014-2017. https://doi.org/10.19102/icrm.2015.060503   DOI
33 Habib A, Irfan M, Baddour LM, Le KY, Anavekar NS, Lohse CM, et al. Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. Europace. 2013;15(2):227-235. https://doi.org/10.1093/europace/eus292   DOI
34 Mittal S, Shaw RE, Michel K, Palekar R, Arshad A, Musat D, et al. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope. Heart Rhythm. 2014;11(4):595-601. https://doi.org/10.1016/j.hrthm.2013.12.013   DOI